Modulation by bryostatin 1 of the in vitro radioprotective effects of the GM-CSF/IL-3 fusion protein, PIXY 321, on normal human myeloid progenitors
- 30 September 1993
- Vol. 5 (5) , 490-497
- https://doi.org/10.1016/1043-4666(93)90040-c
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte-macrophage progenitors to recombinant GM-CSFBritish Journal of Haematology, 1991
- Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cellsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Interleukin‐1 regulation of hematopoietic growth factor production by human stromal fibroblastsJournal of Cellular Physiology, 1988
- Response of Human Bone Marrow Progenitor Cells to X-raysin VitroInternational Journal of Radiation Biology, 1987
- The Human Hematopoietic Colony-Stimulating FactorsScience, 1987
- Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skinCarcinogenesis: Integrative Cancer Research, 1987
- Studies and Perspectives of Protein Kinase CScience, 1986
- Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.The Journal of Experimental Medicine, 1984
- Interleukin 1 is more than an interleukinImmunology Today, 1982
- Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen.Journal of Clinical Investigation, 1979